Adrian Dobs

Professor of Medicine and Oncology
Johns Hopkins University School of Medicine

ADRIAN S. DOBS, MD, MHS
Adrian Sandra Dobs, MD, MHS, is Professor of Medicine and Oncology and Director of the Johns Hopkins Clinical Research Network of the Johns Hopkins Institute for Clinical and Translational Research (JHCRN). Dr Dobs is also Director of the Johns Hopkins Center for the Reduction of Cancer Disparities of the Johns Hopkins Comprehensive Cancer. The JHCRN is a multi-institutional collaboration linking academic and community hospitals in the mid-Atlantic United States.
Dr Dobs received her undergraduate degree from Cornell University, a medical degree from Albany Medical College, in New York, and completed an internship in internal medicine at Montefiore Hospital, Albert Einstein College of Medicine, in the Bronx, New York. She held a fellowship in endocrinology from Johns Hopkins University School of Medicine and earned a master in health sciences degree in cardiovascular epidemiology at the Johns Hopkins University Bloomberg School of Public Health.
Dr Dobs is an investigator on several NIH-funded studies evaluating the relationship of sex hormones and cardiovascular risk. She lectures in the United States and internationally in these areas, as well as aging and testosterone therapy and testosterone and cardiovascular disease.
With book chapters, monographs, and journal articles, as well as television and Web contributions, Dr Dobs has published extensively on topics that include sex hormones and its relationship to metabolic disorders. Journals publishing her research include the New England Journal of Medicine, Journal of Clinical Endocrinology and Metabolism, JAIDS, and Journal of Andrology. She co-chairs the International Registry for Hypogonadal Men.
Dr Dobs is very active in mentoring medical students and postdoctoral fellows and was honored by the Johns Hopkins University School of Medicine with the David M. Levine Excellence in Mentoring Award.

Disclosure information not submitted.

Presentation(s):

• Emerging Options for the Oral Treatment of Male Hypogonadism: Panel Discussion

  Saturday, May 14, 2022
  4:20 PM – 4:50 PM